Cargando…
βKlotho Inhibits Cell Proliferation by Downregulating ELK4 and Predicts Favorable Prognosis in Prostate Cancer
OBJECTIVE: Prostate cancer (PCa) ranks as the second common malignancy in males worldwide. Although conspicuous progressions in diagnosis and treatment have been achieved in the past decades, the prognosis expectation of PCa remains unsatisfied yet. To improve the prognosis prediction of PCa, more s...
Autores principales: | Mao, Changlin, Dong, Wei, Lu, Jiaju, Zhang, Zhao, Wu, Hongliang, Ghavamian, Armin, Bi, Dongbin, Gao, Pei, Liu, Zhao, Ding, Sentai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366951/ https://www.ncbi.nlm.nih.gov/pubmed/34408497 http://dx.doi.org/10.2147/CMAR.S320490 |
Ejemplares similares
-
Elevated expression of HIF-lα in actively growing prostate tissues is associated with clinical features of benign prostatic hyperplasia
por: Wu, Fei, et al.
Publicado: (2016) -
βKlotho inhibits androgen/androgen receptor-associated epithelial-mesenchymal transition in prostate cancer through inactivation of ERK1/2 signaling
por: Liu, Zhao, et al.
Publicado: (2018) -
Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells
por: Liu, Zhao, et al.
Publicado: (2016) -
TIPE1 Inhibits Breast Cancer Proliferation by Downregulating ERK Phosphorylation and Predicts a Favorable Prognosis
por: Hu, Wei, et al.
Publicado: (2019) -
A Potent Chemotherapeutic Strategy with Eg5 Inhibitor against Gemcitabine Resistant Bladder Cancer
por: Sun, Liang, et al.
Publicado: (2015)